Not all breast cancers are alike. Although advances in medical treatment have improved overall breast cancer survival rates tremendously over the last 40 years, some forms of the disease such as triple-negative breast cancer are much more aggressive than other types, with fewer treatment options. The survival rates for patients with these aggressive forms of the disease are still very low, and women under 40 and women with African or Hispanic ancestry are more likely to be impacted by TNBC. Our mission is to improve health outcomes for these women through TNBC research, early detection and breast health education.